Merck's Mumps Vaccine Controversy: Class-Action Lawsuit Alleges Anticompetitive Behavior, Court Shields From Liability
In the late 1990s, the FDA expressed concerns regarding the diminishing potency of Merck & Co., Inc.’s (NYSE:MRK) mumps ...
pharmaphorum6y
Moderna and Merck expand partnership to develop new cancer vaccines
Moderna and Merck & Co have expanded their partnership to develop and commercialise novel personalised messenger RNA (mRNA) cancer vaccines. This expansion of their 2016 collaboration will ...
Yahoo Finance1mon
Merck, Pfizer lifted as CDC backs broader use of pneumococcal vaccines
That shot protects against 21 types of the bacteria that cause pneumococcal disease, including eight not covered by other vaccines. Merck has said those eight account for more than one-quarter of ...